{"result": {"id": "chatcmpl-440", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Breast Cancer Research Network\",\n    \"summary\": \"This network focuses on breast cancer research, with a particular emphasis on angiogenesis and its role in tumor growth. The network comprises researchers, clinicians, and pharmaceutical companies working together to develop new treatments for this disease. Key entities include the University of California San Francisco (UCSF), Genentech, and several clinical trial organizations.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The Breast Cancer Research Network has a significant impact on the field due to its extensive research efforts and collaborations with leading institutions and companies. The network's work directly contributes to advancements in breast cancer treatment and understanding.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significant progress is being made in understanding the role of angiogenesis in breast cancer progression.\",\n            \"explanation\": \"The network has been instrumental in identifying key molecules involved in angiogenesis, such as sFLT1 and VEGF. These findings have led to the development of new therapies targeting these pathways. Clinical trials are underway to evaluate the efficacy of these novel treatments. The network's research also focuses on developing more effective delivery systems for anti-angiogenic drugs, aiming to improve patient outcomes. This includes exploring liposomes as a potential delivery vehicle for LSE, which has shown promising results in preclinical studies.\"\n        },\n        {\n            \"summary\": \"The network is actively involved in clinical trials and collaborations with pharmaceutical companies.\",\n            \"explanation\": \"Several clinical trials are being conducted to evaluate the efficacy of new anti-angiogenic drugs in breast cancer patients. The network collaborates with pharmaceutical companies like Genentech, which has developed several promising therapies targeting angiogenesis. These partnerships facilitate the translation of research findings into real-world applications and contribute to the development of effective treatments for breast cancer.\"\n        },\n        {\n            \"summary\": \"The network's research is highly impactful due to its focus on translational medicine.\",\n            \"explanation\": \"The Breast Cancer Research Network prioritizes translating basic research findings into clinical practice. This approach ensures that new discoveries are implemented in the development of effective treatments for patients. The network actively engages with clinicians and researchers from various disciplines, fostering a collaborative environment that accelerates the translation process.\"\n        },\n        {\n            \"summary\": \"The network's impact extends beyond breast cancer research.\",\n            \"explanation\": \"The network's findings have broader implications for other cancers and diseases. The understanding of angiogenesis in tumor growth can be applied to other areas of medicine, such as cardiovascular disease and wound healing. This interdisciplinary approach allows the network to contribute to a wider range of scientific advancements.\"\n        },\n        {\n            \"summary\": \"The network's success is driven by its strong leadership and collaborative culture.\",\n            \"explanation\": \"The Breast Cancer Research Network has a dedicated team of researchers, clinicians, and administrators who work together to achieve common goals. The network fosters a collaborative environment where ideas are shared, expertise is leveraged, and resources are pooled to maximize impact. This collaborative approach ensures that the network remains at the forefront of breast cancer research.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743143007, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 655, "prompt_tokens": 2048, "total_tokens": 2703, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n5234,BRCA,\"The **BRCA** entity refers to genes associated with breast cancer.  Specifically, patients with mutations in the **BRCA** genes are at an increased risk of developing breast cancer. \n\",11\n2226,ENDOGLIN,\"**Endoglin** is a transmembrane glycoprotein that plays a crucial role in **angiogenesis**, the formation of new blood vessels.  It is an important protein involved in this process, as described by both \"\"Endoglin is a protein involved in angiogenesis\"\" and \"\"Endoglin is a transmembrane glycoprotein involved in angiogenesis\"\". \n\",6\n2478,MDA-MB-231,Cell line used in the study,5\n363,BREAST CANCER,\"**Breast cancer** is a type of cancer affecting the breast tissue. It is a disease being studied, and it has been the focus of research for its treatment and potential causes.  The study of breast cancer has also included investigating how anti-angiogenic drugs affect the disease's progression. Notably, some forms of breast cancer have shown resistance to these treatments. \n\",10\n136,ANGIOGENESIS INHIBITORS,\"Angiogenesis inhibitors are drugs that work by preventing the formation of new blood vessels. These treatments aim to block the process of angiogenesis, which is essential for tumor growth and other pathological conditions. \n\",4\n23,GF,\"The **GF** entity is a potential target for treatment of Triple Negative Breast Cancer (TNBC) and is also a research organization.  This information is derived from the provided descriptions, which suggest that GF is involved in research related to TNBC therapy. \n\",2\n3068,LSE,,2\n2646,LASSO,A statistical method used to remove redundant genes from the analysis,1\n5235,LASSO REGPRESSION,Method used for secondary screening,1\n5236,ROC CURVE ANALYSIS,Used to predict risk of BRCA patients,1\n5237,ANGIOGENESIS-RELATED GENES,,1\n5238,CLUSTER ANALYSIS,,1\n5117,HIGH-RISK GROUP,Group of patients with higher risk of mortality,1\n5118,LOW-RISK GROUP,Group of patients with lower risk of mortality,1\n5241,AGE,,1\n3066,NANOCARRIER VEHICLES,Vehicles used to deliver drugs to the exact site of cancer,1\n3089,DEATHS,Breast Cancer deaths have decreased due to better diagnosis and treatment,1\n3087,2020,Year 2020 saw a significant increase in breast cancer cases,1\n2994,DEHP,\"**DEHP**, also known as Di(2-ethylhexyl)phthalate, is a chemical compound widely used in scientific research. It plays a role in studying various biological processes, including **breast cancer**, **cell development**, and **angiogenesis**.  \n\",4\n1844,GC,\"The **GC** refers to **Gastric Cancer**, a type of cancer that affects the lining of the stomach. It is also known as **Genetic Cancer** due to its genetic basis, and it can be studied in terms of its cellular characteristics. \n\",5\n1841,MIR-361-3P,MicroRNA involved in GC progression,3\n410,TCGA,\"The **TCGA** (Cancer Genome Atlas) is a large-scale project that collects and analyzes genomic data from cancer patients. It contains various datasets, including breast cancer transcriptome data, gastric cancer tissue samples, and gene expression analysis data. The TCGA database is used for studying CRART16 expression and has been utilized in numerous bioinformatic analyses.  It serves as a specific database within the Cancer Genome Atlas, providing genomic data from patients with GC (gastric cancer). \n\",6\n411,GEO,\"The **GEO** database contains genomic data, specifically focusing on breast cancer transcriptome data and genomic data from patients with gastric cancer (GC). \n\",2\n2995,TGFΒ RECEPTOR COMPLEX,,1\n3001,SIV SPROUTING,,1\n1843,TGFB1,\"The **TGFB1** (Transforming Growth Factor beta 1) is a growth factor that plays a crucial role in various biological processes, including angiogenesis.  It is a protein involved in the development and growth of blood vessels. \n\",4\n1840,CIRC_0006089,\"The entity **CIRC_0006089** is a circular RNA (circRNA) that has been studied for its role in gastric cancer (GC).  It has been shown to inhibit tumor growth and promote the expression of TGFB1. This circRNA is upregulated in GC tissues and cells, making it a potential target for therapeutic intervention. \n\",2\n2996,BREAST CANCER RESEARCH,,2\n2999,TGFΒ/SMAD3/VEGF,,1\n3000,MAPK/P38,,1\n5427,MEOX2,\"The **MEOX2** gene is a crucial player in the development and progression of breast cancer. It plays a significant role in angiogenesis, the formation of new blood vessels, which is essential for tumor growth and metastasis.  This gene belongs to the mesenchyme homeobox family and is involved in various biological processes related to tissue formation and differentiation. \n\",5\n4274,VASCULAR DEVELOPMENT,Process of forming new blood vessels,1\n5431,IHC,,1\n5429,BREAST CANCER TISSUE,Tissue samples from breast cancer patients,1\n1853,CLINICAL SETTING,,3\n4597,DRUG DELIVERY SYSTEMS,Systems for delivering drugs to target cells,1\n4598,RESEARCH HOTSPOTS,,1\n1852,ANTI-ANGIOGENIC DRUGS,,1\n61,LIPOSOMES,Tiny bubbles that can deliver drugs,2\n1279,CA,\"**CA** is a compound that may enhance hypoxia-induced Endothelial-to-Mesenchymal Transition (EndMT). It is also a medical institution. \n\",1\n5239,RISK MODEL,,3\n5240,T AND STAGE,,1\n3067,LIVESTOCK,Source of medicinal leech saliva extract (LSE),1\n3296,RECURRENT VARICOSE VEINS,A condition that causes vein swelling and pain,2\n875,SFLT1,A gene downregulated in response to hypoxia and HIF1A overexpression,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n2139,BRCA,ANGIOGENESIS,Angiogenesis is a biological process related to breast cancer (BRCA),157\n1120,ENDOGLIN,ENDOTHELIAL CELLS,Endoglin is highly expressed in endothelial cells and is a prerequisite for developmental angiogenesis,42\n1118,MDA-MB-231,BREAST CANCER,MDA-MB-231 cells are used to study breast cancer,15\n642,BREAST CANCER,ANGIOGENESIS INHIBITORS,Breast cancer has failed to respond to anti-angiogenic drugs,14\n640,GF,BREAST CANCER,GF is researching the mechanisms driving angiogenic signaling in breast cancer,12\n1165,BREAST CANCER,LSE,LSE can inhibit the angiogenesis of breast cancer cells,12\n2140,BRCA,LASSO,Lasso regression was used to construct a risk model related to the prognosis of BRCA patients,12\n2141,BRCA,LASSO REGPRESSION,Risk model based on LASSO regression was established for BRCA patients,12\n2142,BRCA,ROC CURVE ANALYSIS,Risk model used to divide BRCA patients into high-risk and low-risk groups,12\n2143,BRCA,ANGIOGENESIS-RELATED GENES,Used for risk model and cluster analysis in BRCA patients,12\n2144,BRCA,CLUSTER ANALYSIS,Successfully divided BRCA patients into three groups based on angiogenesis-related genes,12\n2146,BRCA,HIGH-RISK GROUP,Successfully divided BRCA patients into high-risk and low-risk groups based on risk model,12\n2147,BRCA,LOW-RISK GROUP,Successfully divided BRCA patients into high-risk and low-risk groups based on risk model,12\n2149,BRCA,AGE,Age of BRCA patients is a risk factor for progression,12\n1164,BREAST CANCER,NANOCARRIER VEHICLES,Nanocarrier vehicles can be used to deliver drugs to the exact site of breast cancer cells,11\n1177,BREAST CANCER,DEATHS,\"Breast Cancer is a major cause of death, but the number of deaths has decreased due to better diagnosis and treatment\",11\n1178,BREAST CANCER,2020,The year 2020 saw a significant increase in breast cancer cases,11\n1115,DEHP,MDA-MB-231,\"The **DEHP** (di(2-ethylhexyl) phthalate) compound has been shown to induce specific signaling pathways in **MDA-MB-231** breast cancer cells.  Exposure to DEHP leads to activation of the TGFβ/SMAD3/VEGF pathway and the MAPK/p38 pathway, both associated with angiogenesis (the formation of new blood vessels). Additionally, prolonged exposure to DEHP has been linked to increased angiogenesis in these breast cancer cells. \n\",9\n634,GC,MIR-361-3P,\"miR-361-3p suppresses GC proliferation, metastasis, glycolysis, angiogenesis, and increased apoptosis\",8\n693,TCGA,GEO,\"Genomic data from patients with GC is available in GEO database\nGenetic data from patients with GC is available in TCGA database\",8\n692,GC,GEO,Genomic data from patients with GC is available in GEO database,7\n1121,ENDOGLIN,TGFΒ RECEPTOR COMPLEX,Endoglin is a auxiliary receptor of the TGFβ receptor complex,7\n1124,ENDOGLIN,SIV SPROUTING,Endoglin knockdown reduces SIV sprouting,7\n636,TGFB1,CIRC_0006089,Circ_0006089 promotes TGFB1 expression,6\n1117,DEHP,BREAST CANCER RESEARCH,Prolonged DEHP exposure can induce angiogenesis in breast cancer cells and is a subject of research,6\n1126,MDA-MB-231,TGFΒ/SMAD3/VEGF,DEHP induces TGFβ/SMAD3/VEGF signaling in MDA-MB-231 cells,6\n1127,MDA-MB-231,MAPK/P38,DEHP induces MAPK/p38 signaling in MDA-MB-231 cells,6\n2221,MEOX2,VASCULAR DEVELOPMENT,MEOX2 is involved in regulating vasculature development,6\n2223,MEOX2,IHC,MEOX2 expression was repressed in breast cancer tissues as confirmed by IHC,6\n2224,MEOX2,BREAST CANCER TISSUE,Low MEOX2 expression indicates densely vascularized tissue,6\n632,MIR-361-3P,CIRC_0006089,The miR-361-3p and circ_0006089 were confirmed to interact,5\n641,GF,CLINICAL SETTING,GF is researching the mechanisms driving angiogenic signaling in breast cancer,5\n1797,DRUG DELIVERY SYSTEMS,ANGIOGENESIS INHIBITORS,Drug delivery systems are being developed for angiogenic inhibitors,5\n1798,ANGIOGENESIS INHIBITORS,RESEARCH HOTSPOTS,Research on the application of angiogenesis inhibitors in lung cancer treatment is a hot topic,5\n644,ANTI-ANGIOGENIC DRUGS,CLINICAL SETTING,Anti-angiogenic drugs are being used in clinical settings for breast cancer treatment,4\n1167,LIPOSOMES,LSE,Medicinal leech saliva extract (LSE) is encapsulated in liposomes,4\n2148,CA,RISK MODEL,CA developed the risk model for predicting patient progression,4\n2150,RISK MODEL,T AND STAGE,Risk model is correlated with T and stage of BRCA patients,4\n1166,LIVESTOCK,LIPOSOMES,Medicinal leech saliva extract (LSE) is derived from livestock,3\n1264,RECURRENT VARICOSE VEINS,SFLT1,Patients with recurrent varicose veins show a significant drop in sFLT1 levels,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_e2df154c3796cf0769dce55190e635339cf523937a853129ccbd00fd320498ca_v2"}